MiMedx Group, Inc.

NASDAQ:MDXG

Biotechnology

Healthcare
$3.18 +2.22%

+$0.08 today

Market cap
$464.04M
Beta
1.46
P/E (TTM)
17.8
EPS (TTM)
$0.21
52W Low $3.03High $7.99

Volume 1.51M

Average 1.55M

MDXG Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

MiMedx Group, Inc.NASDAQ: MDXG

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 148.45M shares rose 0.8% year over year, in line with the +0.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +9.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.8% holds above the trailing-twelve-month pace of +0.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
148.45M+0.4% QoQ
Last fiscal yearDec 2025
147.79M+0.6% YoY
LTMMar 2026
148.01M+0.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.8%——
1 year+0.6%——
3-year CAGR+9.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
147.79M USD
Year-over-year change
+0.6%
4-year CAGR
+7.6%

Weighted Avg Shares vs competitors

How MDXG compares with its peers on the latest reported figures

  • MDXG's LTM Mar 2026 weighted avg shares of 148.01M shares is the 2nd highest of the 8 companies compared; the peer median is 21.36M shares.
  • Its year-over-year change of +0.6% is the 6th highest of 8, against a peer median of +2.5%.
  • Over three fiscal years its annual growth of +9.4% compares with a peer median of +10.7%.
MDXG Competitors Peer median
Weighted Avg Shares for MDXG and competitors
Company Period LTM YoY 3-year CAGR
LCTXLineage Cell Therapeutics, Inc.LTM Mar 2026233.09M +16.0%+10.7%
MDXGMiMedx Group, Inc.LTM Mar 2026148.01M +0.6%+9.4%
ORGOOrganogenesis Holdings Inc.LTM Mar 2026127.11M -2.8%-0.9%
CELUCelularity Inc.LTM Dec 202524.87M +13.6%+22.3%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
BSEMBioStem Technologies, Inc.LTM Jun 202616.91M +2.5%+13.6%
MDWDMediWound Ltd.LTM Mar 202611.89M +16.1%+31.6%
SMTISanara MedTech Inc.LTM Mar 20268.65M +1.5%+2.9%
Peer median (excluding MDXG) 21.36M+2.5%+10.7%

Competitors are the stored peer set for MDXG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue242.02M267.84M321.48M348.88M418.63M
Cost of Revenue39.63M48.32M54.63M60.07M73.01M
Gross Profit202.39M219.53M266.84M288.81M345.62M
Gross Margin83.6%82.0%83.0%82.8%82.6%
Research & Development9.93M12.7M12.67M12.34M15.1M
Selling, General & Admin194.85M220.85M216.3M216.39M266.19M
Operating Expenses209.44M234.25M229.73M229.94M281.29M
Depreciation & Amortization5.18M4.05M3.43M6.04M14.88M
EBITDA(1.89M)(10.69M)40.52M65.35M82.93M
EBITDA Margin-0.8%-4.0%12.6%18.7%19.8%
Operating Income(7.05M)(14.73M)37.12M58.87M63.89M
Operating Margin-2.9%-5.5%11.5%16.9%15.3%
Interest Income00004.72M
Interest Expense4.98M5.02M6.46M1.01M1.78M
Other Income / Expenses(5M)(5.02M)(6.48M)(1.57M)2.38M
Income Before Tax(12.05M)(19.75M)30.63M57.29M66.26M
Pre-Tax Margin-5.0%-7.4%9.5%16.4%15.8%
Income Tax Expense247K206K(36.81M)15.3M17.68M
Net Income(12.3M)(30.2M)67.44M42.42M48.58M
Net Margin-5.1%-11.3%21.0%12.2%11.6%
EPS (Basic)(0.09)(0.27)0.480.290.33
EPS (Diluted)(0.09)(0.27)0.380.280.32
Weighted Avg Shares110.35M112.91M116.5M146.98M147.79M
Weighted Avg Shares (Diluted)110.35M112.91M145.96M149.05M149.72M

MiMedx Group, Inc.

NASDAQ:MDXG

Intrinsic Alpha fair value

Locked

Current Price

$3.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.